![Kimberly Weber](https://www.lathambiopharm.com/wp-content/uploads/2024/07/Kim-Weber_headshot_revised-background-2024.jpg)
Ms. Weber has more than 20 years of experience leading and performing research in academic and industry laboratories in the areas of immunology, cell biology, molecular biology, virology, microbiology, and assay development and validation, with more than eight years of experience in the management of government and commercial programs.
As the Associate Director for LBG’s PMO, she provides program management and systems integration oversight and support for product development programs across a variety of product types and indications. Ms. Weber previously served as Project/Program Manager for the In Vitro Assay Services Department at Battelle, managing highly complex biomedical research programs focused on assay development, diagnostic testing and evaluation, and nonclinical toxicology. She also served as a Research Scientist in the In Vitro Assay Services Department at Battelle, where she led development and validation of immunology and molecular-based assays for biothreat, infectious disease, and pharmaceutical products targets. She started her work at Battelle as an analyst performing high-throughput sample analysis supporting infectious disease vaccine programs.
Ms. Weber began her career studying an in vitro model for Autosomal Dominant Polycystic Kidney Disease. She is a graduate of Randolph-Macon College. In addition, she received her Project Management Professional (PMP®) certification from the Project Management Institute (PMI).